Standout Papers

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Mono... 2013 2026 2017 2021 491
  1. Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma (2013)
    William W. Busse, Stephen T. Holgate et al. American Journal of Respiratory and Critical Care Medicine
  2. A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease (2016)
    Stephan R. Targan, Brian G. Feagan et al. The American Journal of Gastroenterology

Immediate Impact

23 from Science/Nature 74 standout
Sub-graph 1 of 19

Citing Papers

A natural experiment on the effect of herpes zoster vaccination on dementia
2025 StandoutNature
GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
1 intermediate paper

Works of Yun Chon being referenced

A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
2010

Author Peers

Author Last Decade Papers Cites
Yun Chon 553 1038 411 932 42 2.8k
Giulio Cavalli 360 875 354 1008 100 3.6k
Bruce A. Pussell 235 378 99 549 87 2.4k
C.E. Hack 736 328 156 1160 75 3.2k
Erika Gromnica‐Ihle 969 404 414 1010 84 4.6k
N. Tvede 139 413 196 584 48 2.2k
Joseph J. Bunim 237 1624 581 551 70 4.3k
Rasheed A. Balogun 963 245 197 1002 66 3.6k
P. C. Limburg 324 421 209 1249 52 3.6k
Pascale Roux‐Lombard 312 432 156 1311 66 3.6k
Bo Baslund 213 521 296 603 71 2.7k

All Works

Loading papers...

Rankless by CCL
2026